Yayın:
Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer

Sadeleştirilmiş öğe sayfası
dc.contributor.authorTurhal, N. S.
dc.contributor.authorEnes Erul
dc.contributor.authorMustafa Seyyar
dc.contributor.authorÖzge Gümüşay
dc.contributor.authorErtuğrul Bayram
dc.contributor.authorBurçin Çakan Demirel
dc.contributor.authorÖmer Acar
dc.contributor.authorSercan Aksoy
dc.contributor.authorNaziyet Köse Baytemür
dc.contributor.authorElif Şahin
dc.contributor.authorDevrim Çabuk
dc.contributor.authorGül Başaran
dc.contributor.authorSemra Paydaş
dc.contributor.authorArzu Yaren
dc.contributor.authorDeniz Can Güven
dc.contributor.authorAtike Pınar Erdoğan
dc.contributor.authorUmut Demırcı
dc.contributor.authorAlper Yaşar
dc.contributor.authorİbrahim Vedat Bayoğlu
dc.contributor.authorMutlu Hızal
dc.contributor.authorBurcu Gülbağcı
dc.contributor.authorNail Paksoy
dc.contributor.authorSena Ece Davarcı
dc.contributor.authorFunda Yılmaz
dc.contributor.authorÖzlem Doğan
dc.contributor.authorSibel Oyucu Orhan
dc.contributor.authorErkan Kayıkçıoğlu
dc.contributor.authorAli Aytac
dc.contributor.authorMerve Keskinkılıç
dc.contributor.authorEda Eylemer Mocan
dc.contributor.authorOlçun Ümit Ünal
dc.contributor.authorEsra Aydın
dc.contributor.authorHakan Yucel
dc.contributor.authorDeniz Işık
dc.contributor.authorÖnder Eren
dc.contributor.authorBaşak Oyan Uluç
dc.contributor.authorMelike Özçelik
dc.contributor.authorİlhan Hacıbekiroğlu
dc.contributor.authorAdnan Aydıner
dc.contributor.authorHacer Demir
dc.contributor.authorBerna Öksüzoğlu
dc.contributor.authorEbru Cilbir
dc.contributor.authorErdem Çubukçu
dc.contributor.authorBülent Çetin
dc.contributor.authorEsin Oktay
dc.contributor.authorCihan Erol
dc.contributor.authorSadi Kerem Okutur
dc.contributor.authorNilgün Yıldırım
dc.contributor.authorAli Alkan
dc.contributor.authorFatih Selçukbırıcık
dc.contributor.authorAsude Aksoy
dc.contributor.authorYusuf Karakaş
dc.contributor.authorGülhan Özkanlı
dc.contributor.authorBerna Bozkurt Duman
dc.contributor.authorDinçer Aydın
dc.contributor.authorÖzgecan Dülgar
dc.contributor.authorMuhammed Muhiddin Er
dc.contributor.authorFatih Teker
dc.contributor.authorTuğba Yavuzşen
dc.contributor.authorMusa Barış Aykan
dc.contributor.authorAli İnal
dc.contributor.authorYakup İriağaç
dc.contributor.authorNurhan Önal Kalkan
dc.contributor.authorMurat Keser
dc.contributor.authorTeoman Şakalar
dc.contributor.authorSerkan Menekşe
dc.contributor.authorEngin Kut
dc.contributor.authorBurak Bi̇lgi̇n
dc.contributor.authorMüge Karaoğlanoğlu
dc.contributor.authorVeli Sunar
dc.contributor.authorÖzlem Özdemir
dc.contributor.authorN. S. Turhal
dc.contributor.authorNuri Karadurmuş
dc.contributor.authorBülent Yalçın
dc.contributor.authorMehmet Alı Nahıt Şendur
dc.contributor.orcid0000-0002-5328-6554
dc.contributor.orcid0000-0002-2487-2087
dc.contributor.orcid0000-0002-4841-7994
dc.contributor.orcid0000-0002-6236-9829
dc.contributor.orcid0000-0001-8713-7613
dc.contributor.orcid0000-0003-0734-0692
dc.contributor.orcid0000-0003-4408-1976
dc.contributor.orcid0000-0003-4984-1049
dc.contributor.orcid0000-0002-3587-2517
dc.contributor.orcid0000-0002-1976-3951
dc.contributor.orcid0000-0002-7871-6311
dc.contributor.orcid0000-0002-0775-6180
dc.contributor.orcid0000-0003-4642-3693
dc.contributor.orcid0000-0003-1436-8650
dc.contributor.orcid0000-0002-6924-9467
dc.contributor.orcid0000-0003-4859-7574
dc.contributor.orcid0000-0002-4833-6721
dc.contributor.orcid0000-0001-8814-8947
dc.contributor.orcid0000-0002-0481-1084
dc.contributor.orcid0000-0001-5147-4431
dc.contributor.orcid0000-0002-5720-8254
dc.contributor.orcid0000-0003-4636-2595
dc.contributor.orcid0000-0001-8217-3471
dc.contributor.orcid0000-0002-7401-5446
dc.contributor.orcid0000-0002-3342-3144
dc.contributor.orcid0000-0003-0429-8142
dc.contributor.orcid0000-0001-7698-3574
dc.contributor.orcid0000-0003-0210-3153
dc.contributor.orcid0000-0002-6623-6273
dc.contributor.orcid0000-0003-0406-715X
dc.contributor.orcid0000-0002-0333-7405
dc.contributor.orcid0000-0002-1104-5840
dc.contributor.orcid0000-0003-1235-9363
dc.contributor.orcid0000-0002-2756-8646
dc.contributor.orcid0000-0002-0070-0889
dc.contributor.orcid0000-0001-8628-0864
dc.contributor.orcid0000-0002-5974-6339
dc.contributor.orcid0000-0003-3155-8798
dc.contributor.orcid0000-0001-8198-2605
dc.contributor.orcid0000-0002-8253-5046
dc.contributor.orcid0000-0002-1273-1674
dc.contributor.orcid0000-0002-5609-9658
dc.contributor.orcid0000-0003-0205-4590
dc.contributor.orcid0000-0003-3912-7191
dc.contributor.orcid0000-0002-0678-4024
dc.contributor.orcid0000-0002-0583-0295
dc.contributor.orcid0000-0003-4693-6587
dc.contributor.orcid0000-0001-9375-8133
dc.contributor.orcid0000-0001-7538-9119
dc.contributor.orcid0000-0001-9510-9858
dc.contributor.orcid0000-0001-7411-1705
dc.contributor.orcid0000-0002-2823-332X
dc.contributor.orcid0000-0003-1427-3774
dc.contributor.orcid0000-0003-2749-9414
dc.contributor.orcid0000-0002-2134-2128
dc.contributor.orcid0000-0003-1717-8246
dc.contributor.orcid0000-0003-4672-4621
dc.contributor.orcid0000-0003-2520-5953
dc.contributor.orcid0000-0002-1013-5676
dc.contributor.orcid0000-0003-3291-8062
dc.contributor.orcid0000-0002-4431-8948
dc.contributor.orcid0000-0001-7021-6139
dc.date.accessioned2025-11-13T09:46:42Z
dc.date.issued2023-03-01
dc.identifier.doihttps://doi.org/10.2217/fon-2022-1287
dc.identifier.endpage736
dc.identifier.issn1479-6694
dc.identifier.issue10
dc.identifier.openalexW4367835219
dc.identifier.startpage727
dc.identifier.urihttps://hdl.handle.net/11421/2162
dc.identifier.urihttps://doi.org/10.2217/fon-2022-1287
dc.identifier.volume19
dc.language.isoen
dc.relation.ispartofFuture Oncology
dc.rightsrestrictedAccess
dc.subjectPalbociclib
dc.subjectLetrozole
dc.subjectMedicine
dc.subjectMetastatic breast cancer
dc.subjectOncology
dc.subjectInternal medicine
dc.subjectBreast cancer
dc.subjectAromatase inhibitor
dc.subjectHormone receptor
dc.subjectAromatase
dc.subjectCancer
dc.subjectEstrogen receptor
dc.subjectGynecology
dc.subject.sdg3
dc.titleTreatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5064011743

Dosyalar

Koleksiyonlar

Publications